Breaking News Instant updates and real-time market news.

BIIB

Biogen

$384.00

11.2 (3.00%)

17:25
07/25/18
07/25
17:25
07/25/18
17:25

Biogen to hold a webcast

In conjunction with the company's AAIC 2018 presentations, EVP & CMO Sandrock hosts a webcast related to the Company's Alzheimer's Disease Portfolio on July 25 at 6 pm. Webcast Link

  • 25

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

BIIB Biogen
$384.00

11.2 (3.00%)

07/25/18
RHCO
07/25/18
NO CHANGE
Target $392
RHCO
Buy
Biogen price target raised to $392 from $321 at SunTrust
SunTrust analyst Yatin Suneja raised his price target on Biogen to $392 and kept his Buy rating after its Q2 results, saying all key business segments contributed to a top-line beat, while lower cost of goods sold and R&D expenses drove the better than expected earnings. The analyst notes that investors are now focusing on the upcoming release regarding BAN2401 Alzheimer's data, estimating a 20% cognition improvement. Suneja also increased his FY19 expected EPS multiple to 14-times from 12-times as part of his price target revision.
07/25/18
ADAM
07/25/18
NO CHANGE
Target $396
ADAM
Buy
Biogen risk/reward positive into Alzheimer's conference, says Canaccord
Canaccord analyst Sumant Kulkarni noted Biogen reported better than expected Q2 results, which were driven by robust Spinraza sales, higher gross margins, and lower R&D expenses. The analyst said the focus is now on the company's BAN2401 presentation at the Alzheimer conference. He said he likes the risk/reward heading into this event. Kulkarni reiterated his Buy rating and $396 price target on Biogen shares.
07/24/18
JPMS
07/24/18
NO CHANGE
Target $445
JPMS
Overweight
JPMorgan expects 'FOMO' trading for Biogen, ups price target to $445
JPMorgan analyst Cory Kasimov said Biogen's "nice beat-and-raise" report was "an encouraging start" to the Q2 earnings season, adding that its MS franchise remains largely stable. Much of the conference call Q&A focused on Alzheimer's ahead of tomorrow's BAN2401 data presentation and he thought the overall tone of the conversation was "constructive," he tells investors. The analyst, who thinks a significant "fear of missing out" trade may take hold as the highly anticipated aducanumab data readout in early 2020 approaches, raised his price target on Biogen to $445 from $400 and keeps an Overweight rating on the shares.
07/24/18
PIPR
07/24/18
NO CHANGE
Target $400
PIPR
Overweight
Piper raises Biogen target to $400 after BAN2401 'stole the show' from earnings
Piper Jaffray analyst Christopher Raymond raised his price target on Biogen to $400 from $365 after "solid" Q2 results that he said were overshadowed by what "investors are interpreting as highly encouraging commentary" regarding the BAN2401 data that will be presented at tomorrow's AAIC meeting. Given what he sees as the "massive stock re-rating potential" associated with a viable Alzheimer's treatment, he thinks investors should continue to own the stock into tomorrow's BAN2401 data and ahead of full Phase 3 data for aducanumab in 2020. Raymond keeps an Overweight rating on Biogen shares.

TODAY'S FREE FLY STORIES

EGBN

Eagle Bancorp

$44.62

-8.81 (-16.49%)

14:02
07/18/19
07/18
14:02
07/18/19
14:02
Downgrade
Eagle Bancorp rating change  »

Eagle Bancorp downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 15

    Aug

  • 11

    Sep

  • 23

    Sep

14:00
07/18/19
07/18
14:00
07/18/19
14:00
General news
Breaking General news story  »

New York Federal Reserve…

13:55
07/18/19
07/18
13:55
07/18/19
13:55
Conference/Events
Federal Reserve Bank of New York president delivers keynote address »

New York Federal Reserve…

CAMP

CalAmp

$10.59

-0.23 (-2.13%)

13:55
07/18/19
07/18
13:55
07/18/19
13:55
Conference/Events
CalAmp participates in a conference call with Northland »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 06

    Aug

ADMP

Adamis Pharmaceuticals

$1.22

-0.03 (-2.41%)

13:54
07/18/19
07/18
13:54
07/18/19
13:54
Hot Stocks
Adamis Pharmaceuticals, kaleo Inc agree to settle all litigation »

Adamis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

PPG

PPG

$116.58

-0.025 (-0.02%)

13:54
07/18/19
07/18
13:54
07/18/19
13:54
Earnings
PPG sees unfavorable currency translation impact on Q3 sales of $30M-$50M »

"Looking ahead,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 05

    Aug

PPG

PPG

$116.49

-0.115 (-0.10%)

13:49
07/18/19
07/18
13:49
07/18/19
13:49
Hot Stocks
PPG says Q2 EPS impacted by lower global industrial production »

According to prepared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 05

    Aug

ZBRA

Zebra Technologies

$180.92

-16.74 (-8.47%)

13:40
07/18/19
07/18
13:40
07/18/19
13:40
Options
Notable vol spike in Zebra Technologies as shares sell off »

Notable vol spike in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

TELL

Tellurian

$6.98

0.31 (4.65%)

13:40
07/18/19
07/18
13:40
07/18/19
13:40
Recommendations
Tellurian analyst commentary at Stifel »

Tellurian higher after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JLL

Jones Lang LaSalle

$140.05

0.585 (0.42%)

13:32
07/18/19
07/18
13:32
07/18/19
13:32
Conference/Events
Jones Lang LaSalle management to meet with Mizuho »

Meeting with EVP Monahan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

  • 06

    Aug

GOSS

Gossamer Bio

$19.60

-0.48 (-2.39%)

13:30
07/18/19
07/18
13:30
07/18/19
13:30
Options
Gossamer Bio call volume spikes on November purchase wit shares at 52wk lows »

Gossamer Bio call volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
07/18/19
07/18
13:25
07/18/19
13:25
Conference/Events
Cowen healthcare/biotech analysts to hold an analyst/industry conference call »

Healthcare Technology…

PEP

PepsiCo

$132.17

-0.6 (-0.45%)

13:24
07/18/19
07/18
13:24
07/18/19
13:24
Periodicals
Breaking Periodicals news story on PepsiCo »

PepsiCo in talks to buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:20
07/18/19
07/18
13:20
07/18/19
13:20
General news
Treasury's $14 B 10-year TIPS sale was on the soft side »

Treasury's $14 B…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
07/18/19
07/18
13:17
07/18/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
07/18/19
07/18
13:16
07/18/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNIT

Uniti Group

$8.55

-0.03 (-0.35%)

13:15
07/18/19
07/18
13:15
07/18/19
13:15
Options
Uniti Group put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

13:09
07/18/19
07/18
13:09
07/18/19
13:09
General news
10-Yr TIPS Auction Coupon Rate data reported »

10-Yr TIPS Auction Coupon…

13:09
07/18/19
07/18
13:09
07/18/19
13:09
General news
10-Yr TIPS Auction Total Amount data reported »

10-Yr TIPS Auction Total…

TELL

Tellurian

$6.99

0.32 (4.80%)

13:05
07/18/19
07/18
13:05
07/18/19
13:05
Options
Tellurian call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:57
07/18/19
07/18
12:57
07/18/19
12:57
Conference/Events
Stephens architecture analysts to hold analyst/industry conference call nosymbol »

Analysts hold an…

EMR

Emerson

$64.26

-0.4 (-0.62%)

12:55
07/18/19
07/18
12:55
07/18/19
12:55
Options
Emerson put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 06

    Aug

  • 22

    Aug

  • 06

    Sep

12:45
07/18/19
07/18
12:45
07/18/19
12:45
General news
Treasury $14 B 10-year TIPS preview: the auction outlook is mixed. »

Treasury $14 B 10-year…

FB

Facebook

$200.15

-1.82 (-0.90%)

12:43
07/18/19
07/18
12:43
07/18/19
12:43
Periodicals
Instagram hiding 'likes' in more countries to ease pressure, Gadgets says »

Facebook's Instagram…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

DHR

Danaher

$141.79

2.19 (1.57%)

12:40
07/18/19
07/18
12:40
07/18/19
12:40
Recommendations
Danaher analyst commentary at Piper Jaffray »

Danaher price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.